Latest News

  • Growth Improvement in Sales

    Saturday, April 4, 2020
    Growth Improvement in Sales

    Jakarta, April 03, 2020 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced the audited results of the Company for the year 2019.

  • Enseval Commits in Distribution Services of Health Products During the Covid-19 Pandemic

    Wednesday, April 1, 2020
    Enseval Commits in Distribution Services of Health Products During the Covid-19 Pandemic

    Jakarta, April 1 2020 - PT Kalbe Farma Tbk (Kalbe) through one of its subsidiary, PT Enseval Putera Megatrading Tbk (Enseval) is committed to continuing to provide pharmaceutical and health product distribution services to customers to ensure the availability of quality health products in public. In the social distancing situation during the handling of the Covid-19 pandemic, Enseval provides digital health distribution services through the EMOS and MOSHEALTH platforms. Both of these digital platforms are aimed at pharmacies, drug stores or other outlets that must continue to serve the public with their health product needs. 

  • Kalbe Signs a Memorandum of Agreement with the National Disaster Management Agency (BNPB)

    Wednesday, March 25, 2020
    Kalbe Signs a Memorandum of Agreement with the National Disaster Management Agency (BNPB)

    Jakarta, 25 March 2020, PT Kalbe Farma Tbk (Kalbe) today signed a memorandum of understanding with the National Disaster Management Agency (BNPB) in support of the efforts made by BNPB in tackling the spread of the Covid-19 virus. The Memorandum of Agreement is signed directly by Lt. Gen. of the Indonesian Military. Doni Monardo. Chairman of the Task Force for Mitigation Acceleration of Covid-19; while Kalbe is represented by Ongkie Tedjasurja, Director of PT Kalbe Farma TBK., at the BNPB headquarters, Jakarta.

  • Kalbe Prepare Rp. 25 Billion for Help Facing Corona Virus (COVID-19)

    Monday, March 23, 2020
    Kalbe Prepare Rp. 25 Billion for Help Facing Corona Virus (COVID-19)

    Jakarta, March 23, 2020, PT Kalbe Farma Tbk (Kalbe) in support of the Indonesian government in dealing with the Coronavirus outbreak (Covid-19) is providing medicines, multivitamins, health supplements, nutritional products, masks, PPE for health workers, hand sanitizers and other medical devices, as well as conducting Covid-19 examinations through Kalbe's laboratory network. The amount of the budget that has been prepared for the assistance is worth Rp. 25 billion which has been carried out in stages since last week; including toward various health institutions in the community such as hospitals (RS), Eijkman Research Institute, various offices, and community groups. 

  • Preventing the Spread of the New Corona Virus, KlikDokter Launches Free COVID-19 Risk Check Feature

    Thursday, March 19, 2020
    Preventing the Spread of the New Corona Virus,  KlikDokter Launches Free COVID-19 Risk Check Feature

    Jakarta, March 19, 2020 PT Kalbe Farma Tbk (Kalbe) through its subsidiary KlikDokter, has been appointed by the government through the Ministry of Health to help educate the public about correct information regarding COVID-19, one of which is through the digital service of COVID-19 Risk Checking eatures for free. The digital service COVID-19 Risk Checking feature was launched in association with the global COVID-19 pandemic. Currently there is an increase in the number of cases of COVID-19 infection in Indonesia, which causes people to flock to conduct self-examinations. Through this feature, the public can check the symptoms that are related to COVID-19 before visiting the hospital. 

RSS
12345Last